Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.

Authors:	Victoria L Vetter, Josephine Elia, Christopher Erickson, Stuart Berger, Nathan Blum, Karen Uzark, Catherine L Webb, ,
Language:	Eng.
Date:	06-05-2008
Journal:	Circulation (1524-4539)
Release:	Circulation. 2008 May;117(18):2407-23
Abstract:	Abstract not available
Copyright:	Circulation
Full text:	Circulation (DOI) HighWire Press - HTML (needs subscription) Ovid Technologies, Inc. - HTML (needs subscription) Swets Information Services - HTML (needs subscription)
Terms:	Adolescent, American Heart Association, Attention Deficit Disorder with Hyperactivity, Cardiovascular Diseases, Central Nervous System Stimulants, Child, Health Planning Guidelines, Heart Defects, Congenital, Heart Diseases, Humans, Monitoring, Physiologic, Nursing, United States